Search
for
Sort by
Research 841–870 of 1000+
- Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia
- Sulfasalazine for alopecia areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Emerging treatments in alopecia
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- Turner's syndrome associated with psoriasis and alopecia areata
- Histopathologic features of alopecia areata incognito: a review of 46 cases
- Alopecia Areata Associated with Myasthenia Gravis and Thymoma: A Case of Alopecia with Marked Improvement Following Thymectomy and High Level Prednisolone Administration
- Medical Treatment of Noncicatricial Alopecia
- Alopecia areata incognita
- Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valearate in the Management of Localized Alopecia Areata.
- Multiple courses of pulse corticosteroid therapy for alopecia areata
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Intravenous methylprednisolone pulse therapy in severe alopecia areata
- Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation
- Determination of the sildenafil effect on alopecia areata in childhood: An open‐pilot comparison study
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Update on the Genetics of Androgenetic Alopecia, Female Pattern Hair Loss, and Alopecia Areata: Implications for Molecular Diagnostic Testing
- Ayurvedic management of alopecia areata: A case report
- Circumscribed alopecia areata incognita
- Chapter 20. Pathogenesis and Treatment of Alopecias
- Late-Onset Alopecia Areata: A Retrospective Cohort Study
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Changes in Populations of HLA- DR+CD3+ Cells and CD57–CD16+ Cells in Alopecia areata after Corticosteroid Therapy
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- The Latest Trends of Treatment for Alopecia
- Bexarotene gel: A new topical therapy for alopecia areata
- Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Laser Hair Removal in Alopecia Areata of the Scalp: A Novel Therapeutic Approach